First Time Loading...

Krystal Biotech Inc
NASDAQ:KRYS

Watchlist Manager
Krystal Biotech Inc Logo
Krystal Biotech Inc
NASDAQ:KRYS
Watchlist
Price: 162.04 USD 3.05% Market Closed
Updated: Apr 24, 2024

Wall Street
Price Targets

KRYS Price Targets Summary
Krystal Biotech Inc

Wall Street analysts forecast KRYS stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for KRYS is 192.27 USD with a low forecast of 154.53 USD and a high forecast of 218.4 USD.

Lowest
Price Target
154.53 USD
5% Downside
Average
Price Target
192.27 USD
19% Upside
Highest
Price Target
218.4 USD
35% Upside

KRYS Last Price Targets
Krystal Biotech Inc

The latest public price target was made on Apr 15, 2024 by Dae Gon Ha from Stifel Nicolaus , who expects KRYS stock to rise by 26% over the next 12 months. You can read more about this price target by viewing the article on StreetInsider.

Analyst Price Target Date Article
Dae Gon Ha
Stifel Nicolaus
204 USD
Upside 26%
1 week ago
Apr 15, 2024
Krystal Biotech (KRYS) PT Raised to $204 at Stifel
StreetInsider
Dae Gon Ha
Stifel Nicolaus
Price Target 204 USD
Upside/Downside 26%
View Source
Krystal Biotech Inc Competitors:
Price Targets
IMCR
Immunocore Holdings PLC
52% Upside
TRDA
Entrada Therapeutics Inc
66% Upside
PRLD
Prelude Therapeutics Inc
53% Upside
4974
Takara Bio Inc
100% Upside
DVAX
Dynavax Technologies Corp
128% Upside
002880
Shenzhen Weiguang Biological Products Co Ltd
48% Upside
HARP
Harpoon Therapeutics Inc
8% Upside
CDTX
Cidara Therapeutics Inc
51% Downside

Revenue
Forecast

Revenue Estimate
Krystal Biotech Inc

The compound annual growth rate of Krystal Biotech Inc's revenue for the next 3 years is 130%.

N/A
Past Growth
130%
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

Operating Income
Forecast

Operating Income Estimate
Krystal Biotech Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-7%
Average Miss

Net Income
Forecast

Net Income Estimate
Krystal Biotech Inc

The compound annual growth rate of Krystal Biotech Inc's net income for the next 3 years is 183%.

N/A
Past Growth
183%
Estimated Growth
Estimates Accuracy
-42%
Average Miss

See Also

Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is KRYS's stock price target?
Price Target
192.27 USD

According to Wall Street analysts, the average 1-year price target for KRYS is 192.27 USD with a low forecast of 154.53 USD and a high forecast of 218.4 USD.

What is Krystal Biotech Inc's Revenue forecast?
Projected CAGR
130%

The compound annual growth rate of Krystal Biotech Inc's revenue for the next 3 years is 130%.

What is Krystal Biotech Inc's Net Income forecast?
Projected CAGR
183%

The compound annual growth rate of Krystal Biotech Inc's net income for the next 3 years is 183%.